Dr. Kapil Raina

Dr. Kapil Raina currently serves as Vice President of Global/US Market Access - Oncology at Regeneron, a position held since July 2025. Prior to this, Dr. Raina was a Principal at Herspiegel, leading the Market Access Practice from July 2023 to June 2025. Dr. Raina's experience includes strategic consulting for biotech startups and significant roles at HUTCHMED, with a focus on value access pricing and HEOR for oncology and rare diseases, as well as a tenure at Bristol-Myers Squibb, leading global commercial strategies for key oncology products. Earlier experiences include strategic marketing and product management roles in organizations like Novo Nordisk and GSK. Dr. Raina holds an MBA from K J Somaiya Institute and an MBBS from Maulana Azad Medical College, complemented by executive education at The Wharton School.